IRCT20220211053992N15招募中Unknown
In vivo bioequivalence study of Valsartan 80 mg tablet of Pursina pharmaceutical Co. compared to innovator product
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- All
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
- •Age (18-59 years old)
排除标准
- •History of cardiovascular, liver and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
招募中
不适用
Bioequivalence of Valsartan tabletsIRCT20170717035129N1Hakim Pharmaceutical Company26
尚未招募
不适用
Bioequivalence study of Valsartan 160 mg tablet in 24 healthy male under fasting conditionsBioequivalence investigation of the generic Karen Pharma and Food Supplement Co. Valsartan 160 mg tablet with brand Diovan® 160 mg tablet Novartis pharmaceuticals...IRCT20180620040164N18Karen Pharma and Food Supplement Co.24
已完成
不适用
Bioequivalence of ValsartaIRCT20210201050197N2Razak Pharmaceutical Company26
已完成
不适用
Bioequivalence study of Valsartan 160 mgHealthy volunteers.IRCT20200623047902N5Sanamed pharma company24
招募中
Unknown
Bioequivalence study of Telmisartan 80 mg tabletIRCT20200105046010N77Cobel Darou Pharmaceutical Company24